The CAPA That Was Really a Design Decision: Tracing Problems Back to Where They Start
Recurring CAPAs are often design decisions in disguise. MEDEVEX helps medical device teams learn how to trace them back to where they start, and fix them there.
More Hands, Less Speed: Why Adding People to a Late Device Program Backfires
If your program is behind and the plan is “staff up,” it may be worth a second look. MEDEVEX helps teams find the real constraint and pull a late medical device program back in without paying the onboarding tax.
Green Isn’t Done: An Evidence-First Way to Run Medical Device Programs
Have a program that looks green on the dashboard but feels heavy in the room? That is exactly the situation MEDEVEX helps medical device teams work through. A second set of experienced eyes on your risk path is often the cheapest quarter you will ever buy back.
The Cheapest Time to Fix a Medical Device Is Before You Build It
Planning a new device or a redesign? MEDEVEX helps teams engineer manufacturability in from the first design review. Let’s talk about your next launch.
Competitive Compliance: Why the New FDA QMSR Is an Opportunity, Not a Burden
Not sure where your quality system stands against the QMSR? MEDEVEX runs gap assessments and builds quality plans that close gaps on a defined timeline. Reach out for a conversation.
The Hidden Factory Is Eating Your Device Program
MEDEVEX builds high-performing device teams and the visual management to keep them on the critical path.
Five Mistakes That Turn an FDA Inspection Into a Warning Letter
Facing a 483, a Warning Letter, or just want to make sure you never see one? MEDEVEX has guided companies through remediation and back to competitive compliance. Let’s connect.